BDBM22876 CHEMBL998 Claritin Sch 29851 US9138431, LORATADINE (Claritin) US9333199, LORATADINE (Claritin) ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate Loratadine
- Patel, JZ; Ahenkorah, S; Vaara, M; Staszewski, M; Adams, Y; Laitinen, T; Navia-Paldanius, D; Parkkari, T; Savinainen, JR; Walczynski, K; Laitinen, JT; Nevalainen, TJ Loratadine analogues as MAGL inhibitors. Bioorg Med Chem Lett 25: 1436-42 (2015)
- Wang, EJ; Casciano, CN; Clement, RP; Johnson, WW Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein. Drug Metab Dispos 29: 1080-3 (2001)
- Lewis, TA; Young, MA; Arrington, MP; Bayless, L; Cai, X; Collart, P; Eckman, JB; Ellis, JL; Ene, DG; Libertine, L; Nicolas, JM; Scannell, RT; Wels, BF; Wenberg, K; Wypij, DM Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett 14: 5591-4 (2004)
- Cuboni, S; Devigny, C; Hoogeland, B; Strasser, A; Pomplun, S; Hauger, B; Höfner, G; Wanner, KT; Eder, M; Buschauer, A; Holsboer, F; Hausch, F Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. J Med Chem 57: 9473-9 (2014)
- Lall, MS; Bassyouni, A; Bradow, J; Brown, M; Bundesmann, M; Chen, J; Ciszewski, G; Hagen, AE; Hyek, D; Jenkinson, S; Liu, B; Obach, RS; Pan, S; Reilly, U; Sach, N; Smaltz, DJ; Spracklin, DK; Starr, J; Wagenaar, M; Walker, GS Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure-Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H J Med Chem 63: 7268-7292 (2020)